SIGLEC1 and systemic sclerosis: Siglec-1 (CD169, sialoadhesin) is a marker for macrophage activation and its expression was found to be increased CD14+ monocytes in peripheral blood and on macrophages in dermis of lesional skin of a subset of patients with SSc (125).